SCPHARMACEUTICALS INC. Operating Expenses
SCPHARMACEUTICALS INC. reported Operating Expenses of $36.16 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-22.
Discontinued › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-03-22
- SCPHARMACEUTICALS INC. operating expenses for the quarter ending 2022-12-31 was $9.50M, a 41.38% increase year-over-year.
- SCPHARMACEUTICALS INC. operating expenses for the quarter ending 2022-09-30 was $9.99M, a 69.26% increase year-over-year.
- SCPHARMACEUTICALS INC. operating expenses for the quarter ending 2022-06-30 was $9.42M, a 45.93% increase year-over-year.
- SCPHARMACEUTICALS INC. operating expenses for the quarter ending 2022-03-31 was $7.24M, a 7.40% increase year-over-year.
- SCPHARMACEUTICALS INC. operating expenses for fiscal 2022 was $36.16M, a 40.02% increase from fiscal 2021.
- SCPHARMACEUTICALS INC. operating expenses for fiscal 2021 was $25.82M, a 13.73% decline from fiscal 2020.
- SCPHARMACEUTICALS INC. operating expenses for fiscal 2020 was $29.93M, a 9.03% decline from fiscal 2019.
- SCPHARMACEUTICALS INC. operating expenses for fiscal 2019 was $32.91M, a 10.91% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2022-12-31 | $9.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $19.50M derived: sum of 2 quarters · filed 2023-03-22 | $28.92M derived: sum of 3 quarters · filed 2023-03-22 | $36.16M 10-K · filed 2023-03-22 |
| 2022-09-30 | $9.99M 10-Q · filed 2022-11-09 | $19.42M derived: sum of 2 quarters · filed 2022-11-09 | $26.66M 10-Q · filed 2022-11-09 | $33.38M derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-06-30 | $9.42M 10-Q · filed 2022-08-09 | $16.66M 10-Q · filed 2022-08-09 | $23.38M derived: sum of 3 quarters · filed 2023-03-22 | $29.29M derived: sum of 4 quarters · filed 2023-03-22 |
| 2022-03-31 | $7.24M 10-Q · filed 2022-05-16 | $13.96M derived: sum of 2 quarters · filed 2023-03-22 | $19.87M derived: sum of 3 quarters · filed 2023-03-22 | $26.32M derived: sum of 4 quarters · filed 2023-03-22 |
| 2021-12-31 | $6.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | $12.63M derived: sum of 2 quarters · filed 2023-03-22 | $19.08M derived: sum of 3 quarters · filed 2023-03-22 | $25.82M 10-K · filed 2023-03-22 |
| 2021-09-30 | $5.91M 10-Q · filed 2022-11-09 | $12.36M derived: sum of 2 quarters · filed 2022-11-09 | $19.10M 10-Q · filed 2022-11-09 | $26.27M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $6.46M 10-Q · filed 2022-08-09 | $13.20M 10-Q · filed 2022-08-09 | $20.37M derived: sum of 3 quarters · filed 2022-08-09 | $28.80M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $6.74M 10-Q · filed 2022-05-16 | $13.91M derived: sum of 2 quarters · filed 2022-05-16 | $22.35M derived: sum of 3 quarters · filed 2022-05-16 | $30.02M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $15.61M derived: sum of 2 quarters · filed 2022-03-22 | $23.28M derived: sum of 3 quarters · filed 2022-03-22 | $29.93M 10-K · filed 2022-03-22 |
| 2020-09-30 | $8.44M 10-Q · filed 2021-11-09 | $16.11M derived: sum of 2 quarters · filed 2021-11-09 | $22.76M 10-Q · filed 2021-11-09 | $33.20M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $7.68M 10-Q · filed 2021-08-11 | $14.32M 10-Q · filed 2021-08-11 | $24.76M derived: sum of 3 quarters · filed 2021-08-11 | $31.05M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $6.65M 10-Q · filed 2021-05-12 | $17.08M derived: sum of 2 quarters · filed 2021-05-12 | $23.37M derived: sum of 3 quarters · filed 2021-05-12 | $30.71M derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $10.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | $16.72M derived: sum of 2 quarters · filed 2021-03-23 | $24.06M derived: sum of 3 quarters · filed 2021-03-23 | $32.91M 10-K · filed 2021-03-23 |
| 2019-09-30 | $6.29M 10-Q · filed 2020-11-16 | $13.62M derived: sum of 2 quarters · filed 2020-11-16 | $22.47M 10-Q · filed 2020-11-16 | $27.69M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $7.33M 10-Q · filed 2020-08-13 | $16.18M 10-Q · filed 2020-08-13 | $21.41M derived: sum of 3 quarters · filed 2020-08-13 | $27.25M derived: sum of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | $8.85M 10-Q · filed 2020-05-12 | $14.07M derived: sum of 2 quarters · filed 2020-05-12 | $19.91M derived: sum of 3 quarters · filed 2020-05-12 | $29.82M derived: sum of 4 quarters · filed 2020-05-12 |
| 2018-12-31 | $5.22M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $11.06M derived: sum of 2 quarters · filed 2020-03-24 | $20.97M derived: sum of 3 quarters · filed 2020-03-24 | $29.67M 10-K · filed 2020-03-24 |
| 2018-09-30 | $5.84M 10-Q · filed 2019-11-12 | $15.74M derived: sum of 2 quarters · filed 2019-11-12 | $24.44M 10-Q · filed 2019-11-12 | $31.15M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $9.90M 10-Q · filed 2019-08-07 | $18.60M 10-Q · filed 2019-08-07 | $25.31M derived: sum of 3 quarters · filed 2019-08-07 | $30.56M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $8.70M 10-Q · filed 2019-05-08 | $15.41M derived: sum of 2 quarters · filed 2019-05-08 | $20.66M derived: sum of 3 quarters · filed 2019-05-08 | $27.18M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $6.71M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-21 | $11.96M derived: sum of 2 quarters · filed 2019-03-21 | $18.48M derived: sum of 3 quarters · filed 2019-03-21 | $23.44M 10-K · filed 2019-03-21 |
| 2017-09-30 | $5.25M 10-Q · filed 2018-11-13 | $11.77M derived: sum of 2 quarters · filed 2018-11-13 | $16.73M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $6.52M 10-Q · filed 2018-08-14 | $11.48M 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $4.96M 10-Q · filed 2018-05-07 | |||
| 2016-12-31 | $17.91M 10-K · filed 2019-03-21 |